← Journal

Immune Health

LL-37: Your Body's Own Antibiotic Peptide — Should You Inject More?

LL-37 is a natural antimicrobial peptide sold for immunity and healing. Here's the honest science — vital in the body, but double-edged and untested as an injection.

24 Jun 2026 · 5 min read

Most peptides in the wellness world are foreign molecules you're adding to your body. LL-37 is different and, at first glance, more reassuring: it's a peptide your immune system already makes — a natural antibiotic of sorts, part of your body's first line of defence. That makes the pitch ("boost your own immune peptide!") sound almost self-evidently good. The honest science is more interesting and more cautionary, because LL-37 is one of the clearest examples of a molecule where more is not automatically better.

What is LL-37?

LL-37 is the active form of the only human cathelicidin — a natural antimicrobial peptide encoded by a gene called CAMP. Your skin, gut and immune cells produce it as part of innate immunity: it can punch holes in bacteria, neutralise bacterial toxins, recruit immune cells, and support wound healing and new blood-vessel growth 1. In other words, it's a genuinely important, multitasking part of how your body defends and repairs itself.

Because it's a real immune molecule with real functions, researchers are interested in it — and marketers have followed, selling injectable LL-37 to "boost immunity", fight stubborn infections, and accelerate healing. The biology is real. The leap to "so you should inject more" is where it gets complicated.

The double-edged sword

Here's the crucial part the marketing skips. LL-37 isn't simply "good"; it's double-edged, and the dose and context decide which edge you get. The same peptide that defends you can, in excess or in the wrong place, drive inflammation and disease:

  • In psoriasis, excess LL-37 helps trigger the autoimmune cascade that inflames the skin 3.
  • In rosacea, abnormal processing of cathelicidin produces LL-37 fragments that cause redness, inflammation and visible blood vessels 1.
  • LL-37 has also been implicated in other inflammatory and autoimmune conditions, where it can act as a self-antigen that the immune system over-reacts to 2.

So your body keeps LL-37 under tight control for a reason. Deliberately flooding the system with more of it isn't obviously "boosting immunity" — it could just as plausibly tip you toward the inflammatory side of the ledger.

What's the actual evidence for injecting it?

Minimal. The rich science on LL-37 is about its natural roles in immunity and disease — not about whether giving people extra LL-37 as an injection is safe or beneficial. There are essentially no robust human trials of injectable LL-37 as an immune-boosting or healing treatment. Researchers are exploring LL-37-inspired compounds for wound dressings and antibiotics, but that's a long way from a vial sold online. As with the rest of the peptide category, interesting biology has run far ahead of any human proof.

The approval and sourcing problem

LL-37 is not an approved medicine, and what's sold is an unregulated "research" peptide with the usual unknowns of purity, dose and sterility. Layer that on top of the double-edged biology and you have a compound where even the theory of self-injecting is shaky — you're not adding a simple "more defence" dial, you're nudging a tightly regulated, pro-inflammatory- capable system in the dark.

What we see at the clinic

LL-37 appeals to people drawn to the idea of strengthening their own immunity "naturally" — and we get it. We point out the catch: LL-37 is genuinely important, but your body controls it carefully precisely because too much is linked to inflammatory and autoimmune disease. "Boost your natural antibiotic" sounds great until you remember it's also a driver of psoriasis and rosacea. There are no human trials telling us that injecting it helps, and good reasons to suspect it could harm. For immune resilience, the proven foundations — sleep, nutrition, exercise, vaccines, treating underlying chronic inflammation — remain far wiser than an unregulated peptide with a known dark side.

Common questions

Does LL-37 boost immunity? It's a real part of your innate immune defence 1. But there's no good human evidence that injecting extra LL-37 safely "boosts" immunity — and excess is linked to inflammatory disease.

Is it safe to inject? Unknown, and there's specific reason for caution: too much LL-37 is implicated in psoriasis, rosacea and autoimmunity 23. It's also unapproved and unregulated.

Why is a "natural" molecule risky? Because natural doesn't mean "safe in any amount". Your body keeps LL-37 tightly balanced; flooding the system overrides that control.

Is there any legitimate medical use? LL-37-inspired ideas are being researched for wound care and new antibiotics, but that's early research — not the injectable "immune booster" sold online.

Key takeaway

LL-37 is a genuinely important peptide — your own natural antimicrobial, central to immunity and healing. But it's a textbook double-edged molecule: in excess it's implicated in psoriasis, rosacea and autoimmune inflammation, which is exactly why your body keeps it on a tight leash. There are no solid human trials for injecting it, it isn't approved, and "more of a natural defence" is precisely the kind of reasoning the biology warns against. Fascinating science; not a wise thing to inject.

Sources

  1. Reinholz M. et al. (2012) — Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease (review, PMC)
  2. Review — Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease (PMC)
  3. Lande R. et al. — Cathelicidin LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands (PMC)

For general information and education only — not medical advice. Read our disclaimer.